Tuesday, 24 July 2018

Biogen quarterly sales rise 9 percent

Biogen Inc reported a 9 percent rise in quarterly revenue on Tuesday, helped by demand for its spinal muscular atrophy drug Spinraza.


Posted by at

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)